Permira seeks $4bn for sale of contract drugmaker Cambrex

All NewsSeptember 6, 2025

Trump’s threat of pharmaceutical tariffs has boosted investor interest in US drugmakers

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent